These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21733839)

  • 1. The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.
    Morgan HP; McNae IW; Nowicki MW; Zhong W; Michels PA; Auld DS; Fothergill-Gilmore LA; Walkinshaw MD
    J Biol Chem; 2011 Sep; 286(36):31232-40. PubMed ID: 21733839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphoglycerate kinases from Trypanosoma brucei. A comparison of the glycosomal and the cytosolic isoenzymes and their sensitivity towards suramin.
    Misset O; Opperdoes FR
    Eur J Biochem; 1987 Feb; 162(3):493-500. PubMed ID: 3830152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.
    Mancini F; Toro CM; Mabilia M; Giannangeli M; Pinza M; Milanese C
    Biochem Pharmacol; 1999 Sep; 58(5):851-9. PubMed ID: 10449196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
    Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin.
    Morty RE; Troeberg L; Pike RN; Jones R; Nickel P; Lonsdale-Eccles JD; Coetzer TH
    FEBS Lett; 1998 Aug; 433(3):251-6. PubMed ID: 9744805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase.
    Morgan HP; Walsh MJ; Blackburn EA; Wear MA; Boxer MB; Shen M; Veith H; McNae IW; Nowicki MW; Michels PA; Auld DS; Fothergill-Gilmore LA; Walkinshaw MD
    Biochem J; 2012 Nov; 448(1):67-72. PubMed ID: 22906073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
    Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis.
    Nowicki MW; Tulloch LB; Worralll L; McNae IW; Hannaert V; Michels PA; Fothergill-Gilmore LA; Walkinshaw MD; Turner NJ
    Bioorg Med Chem; 2008 May; 16(9):5050-61. PubMed ID: 18387804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mg-dependent ecto-ATPase in Leishmania amazonensis and its possible role in adenosine acquisition and virulence.
    Berrêdo-Pinho M; Peres-Sampaio CE; Chrispim PP; Belmont-Firpo R; Lemos AP; Martiny A; Vannier-Santos MA; Meyer-Fernandes JR
    Arch Biochem Biophys; 2001 Jul; 391(1):16-24. PubMed ID: 11414680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of suramin on Trypanosoma cruzi.
    Bisaggio DF; Adade CM; Souto-Padrón T
    Int J Antimicrob Agents; 2008 Mar; 31(3):282-6. PubMed ID: 18191547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphate removal induces a major conformational change in Leishmania mexicana pyruvate kinase in the crystalline state.
    Tulloch LB; Morgan HP; Hannaert V; Michels PA; Fothergill-Gilmore LA; Walkinshaw MD
    J Mol Biol; 2008 Nov; 383(3):615-26. PubMed ID: 18775437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of pyruvate kinases display evolutionarily divergent allosteric strategies.
    Morgan HP; Zhong W; McNae IW; Michels PA; Fothergill-Gilmore LA; Walkinshaw MD
    R Soc Open Sci; 2014 Sep; 1(1):140120. PubMed ID: 26064527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphoglycerate kinase isoenzymes have distinct roles in the regulation of carbohydrate metabolism in Trypanosoma cruzi.
    Barros-Álvarez X; Cáceres AJ; Michels PA; Concepción JL; Quiñones W
    Exp Parasitol; 2014 Aug; 143():39-47. PubMed ID: 24858924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A STUDY OF GRANULES AND OTHER CHANGES IN PHASE-CONTRAST APPEARANCE PRODUCED BY CHEMOTHERAPEUTIC AGENTS IN TRYPANOSOMES.
    ORMEROD WE; SHAW JJ
    Br J Pharmacol Chemother; 1963 Oct; 21(2):259-72. PubMed ID: 14081657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecto-ATPase activity on the surface of Trypanosoma cruzi and its possible role in the parasite-host cell interaction.
    Bisaggio DF; Peres-Sampaio CE; Meyer-Fernandes JR; Souto-Padrón T
    Parasitol Res; 2003 Oct; 91(4):273-82. PubMed ID: 14574556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin-induced reciprocal changes in glucose and lactate synthesis in renal tubules contribute to its hyperglycaemic action.
    Jagielski AK; Kryśkiewicz E; Bryła J
    Eur J Pharmacol; 2006 May; 537(1-3):205-9. PubMed ID: 16626687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.
    Bültmann R; Trendelenburg M; Starke K
    Br J Pharmacol; 1994 Oct; 113(2):349-54. PubMed ID: 7834182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl Pyruvate Emerges as a Safe and Fast Acting Agent against Trypanosoma brucei by Targeting Pyruvate Kinase Activity.
    Worku N; Stich A; Daugschies A; Wenzel I; Kurz R; Thieme R; Kurz S; Birkenmeier G
    PLoS One; 2015; 10(9):e0137353. PubMed ID: 26340747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
    Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
    J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.